Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 13 | 3 | 12 | — | — | 28 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 12 | 3 | 13 | — | — | 28 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 2 | — | 1 | — | — | 3 |
Drug common name | Insulin icodec |
INN | insulin icodec |
Description | Insuman (insulin 287) is a protein pharmaceutical. Insulin 287 was first approved as Insuman on 1997-02-21. It has been approved in Europe to treat diabetes mellitus. |
Classification | Protein |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4594581 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | P7YU3ED05N (ChemIDplus, GSRS) |